
Magellan Health, Inc. MGLN
Magellan Health, Inc. ROCE Ratio 2011-2025 | MGLN
Annual ROCE Ratio Magellan Health, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 0.78 | 4.48 | 3.1 | 7.52 | 11.32 | 5.62 | 8.22 | 12.95 | 16.9 | 20.01 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.01 | 0.78 | 9.09 |
ROCE Ratio of other stocks in the Health care industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
19.03 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
22.95 | $ 276.37 | 0.62 % | $ 75.7 B | ||
|
Triple-S Management Corporation
GTS
|
0.18 | - | 0.28 % | $ 847 M | ||
|
Humana
HUM
|
15.65 | $ 273.95 | 2.12 % | $ 33 B | ||
|
Centene Corporation
CNC
|
12.02 | $ 40.59 | -0.66 % | $ 21.2 B | ||
|
CVS Health Corporation
CVS
|
11.27 | $ 79.55 | 0.15 % | $ 100 B | ||
|
Molina Healthcare
MOH
|
37.97 | $ 166.33 | -1.28 % | $ 9.55 B | ||
|
UnitedHealth Group Inc.
UNH
|
32.86 | $ 340.29 | -0.45 % | $ 313 B | ||
|
NovoCure Limited
NVCR
|
-35.2 | $ 13.02 | -2.29 % | $ 1.4 B |